Member Info for Noise

Lawrence, one of the less documented PR/banking quirks in the war for big oil is a very curious coincidence between the timing of ban on alcohol and the first cars that could simultaneously run on oil or alcohol.

1908: The Ford Model T is launched, the first 'cheap' car that can run on alcohol. At the time, alcohol is cheaper than oil
1919: US alcohol prohibition begins. Big oil dominates with the competition eliminated, oil barons, banks and shareholders make untold fortunes

What do you think is more likely?

A partner signing up VAL401 for lung cancer
A partner signing up for VAL401 for various adenocarcinoma conditions (including lung pancreatic etc.)
A partner/others getting involved in an IPO for Valiseek?

I believe we are aware that Dr Dilly has at least tabled her requirements and costs for progressing the phase 3 as an IPO (staff, website, clinical funding etc.). The other options are direct partnership?

Frankly I'd quite like someone to just buy out 401 and be rid of the albatross of future funding requirements. That is almost certainly because it suits my investing position tho!

lol. I do chuckle when I read about Trump trying to weaken NATO, he's a difficult to predict chap, but essentially he is a business man who wants a better deal for his country, if he has to ruffle some political feathers to achieve that he does not give a monkeys. The fact he annoys the left wing bedwetters is an added bonus.

If you think I am perhaps being a tad unrealistic, feel free to look up where NATO gets its budget from, here is a ballpark value:

USA: $650bn
UK: $60bn
France $44bn
Germany $40bn
Other 24 NATO members: ~ $80bn

I had not realised the pace of electric/battery powered train rollouts in the UK.

It seems to reduce the costs of re-building bridges/infrastructure (the bulk of the reason for the billions of overspend on electrifying the rail network so far), it seems the latest generation of electric trains on actual order by the UK rail networks include the optional 125-300kWh Li-Ion batteries to cover 10-15mile sections that would otherwise be expensive to modernise.

You assume that price drops are directly linked to broker leaks.

I'm sure it happens, but far more commonly it's because brokers can forward sell stock up to 20 days in advance of an official placing, so IMO it seems far more plausible less ethical brokers are just dumping a ton of stock on the market resulting in a supply glut and price drop. Classic supply and demand, but I wish there was a 'beginners guide to AIM' that would outline the antics of the AIM market to beginners before they were allowed to trade.

IMHO, the AIM market seems almost rigged to provide long term interest rates to bond/finance houses, the bondholders and banks always get their money from the AIM companies, the PIs get shafted on almost all AIM resource shares.

Given that sex hormones drive a whole heap of undesirable growths, I would have thought there would be some recommendations for ladies to occasionally stop using the sex hormone pill to allow resetting of natural processes, in my sheer male ignorance I have no idea what they actually recommend to ladies.

Nomlungu, interesting, appears to just be a generic inhibitor of sex hormones, with the usual suspects as side effects

"Side effects of elagolix include menopausal-like symptoms such as hot flashes night sweats, insomnia, amenorrhea, anxiety, mood changes, and bone loss"

Creeping up to 3p...

As in, Satu will want to advertise her stock, and it seems we have a backlog of trial data to release, so she'll be inclined to release some data!

Interesting time. History suggests a good bit of trial data could be on it's way... there may be a nice jump up over the next few days.

Can't predict the 6 month SP, but the next few days will make interesting viewing.

I have only just got around to watching the long video with George. I thought he was probably a bit more realistic in this video, some interesting bits of information too.

Not sure how I stand long/short right now - probably immediately short, expectations of immediate solid RNS/401 update after the GM/equity is announced.

Sid, Lithium carbonate is generally an earlier stage version of lithium processing, from Li carb you can then make Li Hydroxide.

Li Carbonates are also used in various other industries, aluminium, cement, ceramics, glass, bipolar medications, random stuff like that. Certain cathode chemistries are improved by, or demand lithium hydroxide (I believe NCA and NMC cathodes require it). All have slightly different quirks, minimum levels of contaminants etc.

Amusing that BCN cancelled their equity dilution, genuinely cannot remember the last time an AIM company cancelled an equity dilution.

Grid scale power storage is about 500kg per MWh based on Bacanora Minerals presentations.

So 1GWh = maybe 500 tons

https://arstechnica.com/cars/2018/07/chinese-firm-will-build-battery-factory-in-germany-to-supply-bmw-volkswagen/

On Monday, BMW also announced that it would buy €4 billion ($4.7 billion) in battery cells from CATL, which already has factories in China. €1.5 billion ($1.7 billion) of BMW's purchases would be made in the EU and €2.5 billion ($2.9 billion) would be made in China.

http://www.4-traders.com/BAYERISCHE-MOTOREN-WERKE-435722/news/China-s-CATL-to-build-its-first-European-EV-battery-factory-in-Germany-26895212/

BMW is sourcing raw materials for the cells itself to pass to the battery makers, in particular cobalt, and is currently negotiating long-term contracts.

Duesmann said BMW would only conclude contracts where inhuman conditions and child labor were ruled out. It said it was not sourcing cobalt from mines in Democratic Republic of Congo.

I'm not exactly sure what ends on the current phase i/ii VAL201 trial.

OK so we have drug expansion planned up to 16mg (I think?), but with those results will we have enough numbers to satisfy the phase 2 side of things? Or simply phase 1?

For some reason, I thought phase 2 cancer trials are typically 50-150 patients, and we're probably scraping around 15-25 to the best of my knowledge (not guaranteed to be perfect, but I can only recall 10-12 results being discussed).

At 30m shares about 2 years ago, I could possibly have foreseen a £150m MCAP and 90m shares, not a bad value proposition.

At 450m shares and a request for 900m shares, that ratio starts to look significantly less appealing.

Let's say they get £15m for the 401 partnership, does that basically mean they can run VAL for 2 more years before the next equity rise? ;)

An interesting situation and many viewpoints to decide on appropriate tactics.

I for one, much like the BoD, am primarily focussed on my monetary situation, removing all the emotion from my investment decision, I do wonder if selling most of my stock, then setting a 'buy' order triggered by 3.5p shortly after the equity is announced, then selling at whatever spike is reached, assuming Satu is lining up a 401/201 decent RNS shortly after the equity is sold, as they'll have a moderate overhang of stock to be cleared and brokers must make a profit huh?

Unfortunately, such are the realities on AIM. LTHs stuffed either way.

Not 100% sure how to play this. If they were imminently getting a cheque for £10m would they be giving away half the company for £4m?

If Val folds, who gets 201? Cancer Research UK?

Here's a dare for Satu: Write another one of those "We are pleased to announce massive dilution." RNSs. I could possibly stomach them, but there's always that obligatory word "pleased" in there which just sticks in the throat.

In reality, not entirely sure what other options there are.

It's been a pretty dull day all over the shop. I think the traders are down the pub and the algos are going slow due to the hot weather !